147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
More posts

Cellular fibronectin toolset

Expression vectors encoding human 'cellular' fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) ; […]

Real time no measurement

Real time constant amperometric detection of NO in tissues/cells. This gaseous neurotransmitter has a very short half-life (*5 s) and is usually […]

Apoa2 humanized transgenic mouse – line lambda

The mice are hemizygous for the human apolipoprotein A2 (ApoA2) gene expressed under the control of the homologous promoter (-911/+2045). They are […]

Apoa2 humanized transgenic mouse – line beta

The mice are hemizygous for the human apolipoprotein A2 (ApoA2) gene expressed under the control of the homologous promoter (-911/+2045). They are […]

Apoa2 humanized transgenic mouse – line delta

The mice are hemizygous for the human apolipoprotein A2 (ApoA2) gene expressed under the control of the homologous promoter (-911/+2045). They are […]

Anti-human a2ar

ADONIS is an agonist-like monoclonal antibody directed against an epitope located on the second extracellular loop of the A2A receptor of adenosine. […]

Cardiac overexpression of the human beta3-adrenergic receptor.

Mice with a cardiac ovexpression of the human beta3-adrenergic receptor were produced by microinjection of a construct with A or C isoform gene under […]

Mouse anti-human protein s (pros1) mabs

These mouse monoclonal antibodies are directed against human PROS1, an anti-coagulation factor. They are very specific and recognize 70-kDa protein. […]

More posts

You might also be interested in